“…[26] In general, this kind of assessment is of impor-tance in the course of fine-tuning properties and structureactivity relationships during the drug discovery process.T he membrane permeability and solubility parameters of the modified cyclopeptides 14-16 were compared to the results of in silico calculations.T hus,t his set of nine cross-coupling products (14-16)was submitted to molecular dynamics (MD) simulations followed by calculation of the solvent-accessible polar surface area (abbreviated SAPSA) to result in an in silico assessment of permeability properties in the first instance (Table 2). Thel ow solubility measured for the starting materials (11)(12)(13)was in most of the cases improved by the pyridyl core (see Table 2, entries 4-9 and 12), and on the basis of the PA MPA( Parallel Artificial Membrane Permeability Assay) results,a ll cyclic peptides display high permeability.However,inthe cellular assessment (MDCK;M adin Darby canine kidney cells assay), the position of the pyridyl linkage seems to be sensitive regarding transport across the cellular membrane.A si nt he in silico analyses,t he para-phenylalanine-substituted analogues showed reduced transport rates. Cross-couplingreactions of tyrosine derivatives 3a,b with organozinc halides 5a-e leading to alkylated tyrosine derivatives 6a-f. Boc = tert-butoxycarbonyl, Cbz = benzyloxycarbonyl.…”